Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Biological or biochemical
Reexamination Certificate
2011-03-29
2011-03-29
Parkin, Jeffrey S. (Department: 1648)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Biological or biochemical
C720S724000
Reexamination Certificate
active
07917303
ABSTRACT:
Methods for identifying a motif or a combination of motifs having a Boolean state of predetermined mutations in a set of sequences including a) aligning a set of sequences of ordered motifs represented by a single-character code, b) comparing a reference sequence with the set of sequences aligned in step (a), c) identifying motifs not having mutated simultaneously and/or motifs having mutated simultaneously at least once on at least one sequence of the set and not having mutated on another sequence of the set.
REFERENCES:
patent: 7734421 (2010-06-01), Vanet et al.
patent: WO 99/61658 (1999-12-01), None
Chou, K.-C., 1996, Prediction of Human Immunodeficiency Virus Protease Cleavage Sites in Proteins, Anal. Biochem. 233:1-14.
Draghici, S., and R. B. Potter, 2003, Predicting HIV drug resistance with neural networks, Bioinformatics 19(1):98-107.
Korber, B. T. M., et al., 1993, Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: An information theoretic analysis, Proc. Natl. Acad. Sci. USA 90:7176-7180.
Winslow, D. L., et al., 1995, Limited sequence diversity of the HIV type 1 protease gene from clinical isolates and in vitro susceptibility to HIV protease inhibitors, AIDS Res. Human Retrovir. 11(1):107-113.
Zhang, L, et al., 1999, Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy, The New Engl. J. of Med. 340(21):1605-1613.
HIV Sequence Compendium, 2000, Kuiken, C. L., et al., eds., Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, LA-UR 01-3860, pp. 480-483.
Collins, J. F., and A. F. W. Coulson, 1987, Chapter 13: Molecular sequence comparison and alignment, in Nucleic acid and protein sequenc analysis a practical approach, IRL Press, Washington, DC, pp. 323-358.
Stoll, V., et al., 2003, X-ray crystallographic structure of ABT-378 (lopinavir) bount to HIV-1 protease, Bioorganic & Medicinal Chemistry 10:2803-2806.
Gonzalez, L. M. F., et al., 2003, In vitro hypersusceptibility of human immunodeficiency virus type 1 subtype C protease to lopinavir, Antimicrob. Agents and Chemother. 47(9):2817-2822.
Brouillet, S., et al., 2010, Co-lethality studied as an asset against viral drug escape: the HIV protease case, Biol. Dir. 5-40-1-13.
Robert W. Shafer et al.,Human immunodeficiency virus type I reverse transcriptase and protease mutation search engine for queries, Nature Medicine, vol. 6, No. 11, Nov. 2000, pp. 1290-1292.
Rami Kantor et al.,Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs, Nucleic Acids Research, vol. 29, No. 1, Jan. 2001, pp. 296-299.
Robert W. Shafer et al.,Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database, Nucleic Acids Research, vol. 28, No. 1, Jan. 2000, pp. 346-348.
Robert W. Shafer et al.,Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database, Nucleic Acids Research, vol. 27, No. I, Jan. 1999, pp. 348-352.
P. L. Wesche et al., “DNA Sequence Error Rates in Genbank Records Estimated Using the Mouse Genome as a Reference,”DNA Sequence, Oct./Dec. 2004, vol. 15 (5/6), pp. 362-364.
C. B. Lawrence et al., “Assignment of Position-Specific Error Probability to Primary DNA Sequence Data,”Nucleic Acids Research, 1994, vol. 22, No. 7. pp. 1272-1280.
Eddy, S., “Hidden Markov models,” Curr. Opin. Struct. Biol., vol. 6. pp. 361-365, 1996.
Laurent-Puig, P. et al., “APC gene: database of germline and somatic mutations in human tumors and cell lines,” Nucleic Acids Res Jan. 1, 1998; 26(1): pp. 269-270.
Beroud, C. et al., “p53 and APC gene mutations: software and databases,” Nucleic Acids Res Jan. 1, 1997; 25(1), p. 138.
Papillon, E. et al., “A malignant gastrointestinal stromal tumor in a patient with multiple endocrine neoplasia type 1,” European Journal of Gastroenterology & Hepatology, 2001, 13:207-211.
Gallou, C. et al., “Mutations of the VHL Gene in Sporadic Renal Cell Carcinoma: Definition of Risk Factor for VHL Patients to Develop an RCC,” Human Mutation, 13:464-475 (1999).
Baudry, D. et al., “WT1 Splicing Alterations in Wilms' Tumors,” Clin Cancer Res Oct. 2000; 6(10): pp. 3957-3965.
Hammond, J. et al., “Mutations in Retroviral Genes Associated with Drug Resistance,” The Human Retrovirus and AIDS Compendium, 1999, pp. 542-591.
Chou, K.C., “Prediction of Human Immunodeficiency Virus Protease Cleavage Sites in Proteins,” Anal. Biochem. 1996, 233, pp. 1-14.
Draghici, S. et al., “Predicting HIV drug resistance with neural networks,” Bioinformatics, 19(1), 2003, pp. 98-107.
Rose, P. P. et al., “Detecting hypermutations in viral sequences with an emphasis on G→ A hypermutation,” Bioinformatics, 2000, vol. 26, No. 4, pp. 400-401.
Strimmer, K. et al., “Likelihood-mapping: A simple method to visualize phylogenetic content of a sequence alignment,” PNAS, Jun. 1997, vol. 94, pp. 6815-6819.
Caride, E. et al., “Sexual transmission of HIV-1 isolate showing G→ A hypermutation,” Journal of Clinical Virology, 2002, vol. 23, pp. 179-189.
Collins, J. F. et al., “Chapter 13: molecular sequence comparisons and alignment In Nucleic acid and protein sequence analysis,” IRL Press., 1987, pp. 232-358.
Zhang, L. et al., “Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy,” New England Journal of Medicine, May 1999, vol. 340, No. 21, pp. 1605-1613.
Thompson , J. D et al., “CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice,” Nucleic Acids Research, 1994, vol. 22, No. 22, pp. 4673-4680.
Eddy, S., “Multiple Alignment and multiple sequence based searches,” Trends Guide to Bioinformatics, 1998, pp. 15-18 (preprint).
Brouillet Sophie
Marsan Laurent
Muller-Trutwin Michaela
Ollivier Emmanuelle
Valère Thomas
Centre National de la Recherche Scientifique—CNRS
DLA Piper (LLP) US
Parkin Jeffrey S.
LandOfFree
Method for identifying combinations of motifs that do not... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for identifying combinations of motifs that do not..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for identifying combinations of motifs that do not... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2747019